Mankind Pharma Limited FII & DII Activity

FII Net (₹ Cr)

−3111.94Buy 13,857.58Sell 16,969.52

DII Net (₹ Cr)

+8930.12Buy 19,254.19Sell 10,324.07

FII F&O Net (contracts)

+374795Index + stock futures

5-Day Flow Trend

Date	FII Net (₹ Cr)	DII Net (₹ Cr)
2026-09-04	−3111.94	+8930.12
2026-09-03	−2345.87	+4977.46
2026-09-02	+6688.37	+2812.98
2026-09-01	−7985.88	+4588.88
2026-08-31	−7985.88	+4588.88

AI AnalysisGenerated daily after market close · AI-powered

Today's Institutional Flow

On 2026‑09‑04 the foreign institutional investors (FII) posted a net cash outflow of ₹‑3,111.94 crore, while domestic institutional investors (DII) injected a net cash inflow of ₹ 8,930.12 crore into the market. The contrasting directions highlight a strong domestic appetite against a weakening foreign stance today. Overall net cash flow is positive, driven predominantly by the DII surge.

Trend vs 5‑Day Average

The FII cash outflow of ₹‑3,111.94 crore is milder than the five‑day average outflow of ₹‑3,333.81 crore, indicating a slight easing of foreign selling pressure. Conversely, the DII inflow of ₹ 8,930.12 crore exceeds the five‑day average of ₹ 4,430.43 crore, confirming an elevated domestic buying rhythm relative to recent days.

F&O Positioning Data

FII participants amassed a net long position of ₹ 374,795 crore in futures and options contracts, reflecting continued speculative interest in the derivatives arena. Their index‑futures long‑to‑short ratio stands at 1.2, suggesting a modest bullish bias among foreign traders.

Healthcare Sector Flow

The healthcare segment, which includes Mankind Pharma Limited, has recorded a recent tilt toward DII accumulation and modest FII withdrawal, underpinning a supportive domestic flow environment for the sector.

Market-wide FII/DII data — same for all F&O stocks. Date: 2026-09-04

Same Sector

ALKEMAlkem Laboratories LimitedNeutral APOLLOHOSPApollo Hospitals Enterprise LimitedNeutral AUROPHARMAAurobindo Pharma LimitedNeutral BIOCONBiocon LimitedNeutral CIPLACipla LimitedNeutral

Frequently Asked Questions

What is FII net buying/selling in Mankind Pharma Limited today?

FII (Foreign Institutional Investor) net flow in the Indian cash market today is ₹3,111.94 Cr (net selling) as of 2026-09-04. This market-wide figure applies to all F&O stocks including Mankind Pharma Limited.

What is DII activity in Mankind Pharma Limited today?

DII (Domestic Institutional Investors — mutual funds, insurance companies) net flow is ₹8,930.12 Cr (net buying) today. DIIs often act as a counterbalancing force to FII flows — on days when FIIs sell, DIIs typically provide support.

What is FII F&O net for Mankind Pharma Limited today?

FII net F&O position (index + stock futures combined) is +3,74,795 contracts as of the latest participant OI data. A positive number means FIIs are net long in futures; negative means net short.

Were there any block deals in Mankind Pharma Limited?

Block deal data for Mankind Pharma Limited is tracked daily from NSE's block deal window. On days with activity, the deal value in ₹ Crore is shown on this page.

How does FII/DII data affect Mankind Pharma Limited stock price?

FII and DII flows are market-wide data — all F&O stocks including Mankind Pharma Limited are influenced. When FIIs buy heavily (positive net), it typically supports the broader market. When FII F&O net is strongly positive (long futures), it signals institutional conviction in an uptrend. Combined with Mankind Pharma Limited's individual OI buildup type, this provides a directional framework.